title: Risk factors associated with vancomycin-resistant enterococcus in intensive care unit settings in saudi arabia.
abstract: Background. Vancomycin-resistant enterococci (VRE) are significant nosocomial pathogens worldwide. There is one report about the epidemiology of VRE in Saudi Arabia. Objective. To determine the risk factors associated with VRE infection or colonization in intensive care unit (ICU) settings. Design. This is a descriptive, epidemiologic hospital-based case-control study of patients with VRE from February 2006 to March 2010 in ICU in a tertiary hospital in Saudi Arabia. Methods. Data were collected from hospital records of patients with VRE. The main outcome measure was the adjusted odds ratio estimates of potential risk factors for VRE. Results. Factors associated with VRE included ICU admission for multiorgan failure, chronic renal failure, prior use of antimicrobial agents in the past three months and before ICU admission, gastrointestinal oral contrast procedure, and hemodialysis. Being located in a high risk room (roommate of patients colonized or infected with VRE) was found to be protective. Conclusions. Factors associated with VRE acquisition are often complex and may be confounded by local variables.
authors.affiliation: Internal Medicine Department/Infection Control Section, King Fahad Specialist Hospital, P.O. Box 15215, Dammam 31444, Saudi Arabia.
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Shorman
authors.forename: Jaffar A
authors.initials: JA
authors.lastname: Al-Tawfiq
references.citation: Epidemiol Infect. 2013 May;141(5):1109-14
references.pmid: 22831856
references.citation: J Antimicrob Chemother. 2008 Aug;62(2):279-83
references.pmid: 18440933
references.citation: Ann Saudi Med. 1996 Nov;16(6):625-8
references.pmid: 17429236
references.citation: Infect Control Hosp Epidemiol. 2011 May;32(5):481-9
references.pmid: 21515979
references.citation: Infect Control Hosp Epidemiol. 2003 Apr;24(4):257-63
references.pmid: 12725354
references.citation: Clin Microbiol Infect. 2013 Apr;19(4):E181-9
references.pmid: 23398607
references.citation: J Clin Microbiol. 2007 Oct;45(10):3360-5
references.pmid: 17704282
references.citation: Infect Control Hosp Epidemiol. 2008 May;29(5):398-403
references.pmid: 18419360
references.citation: Ann Saudi Med. 1993 May;13(3):289-93
references.pmid: 17590681
references.citation: Clin Microbiol Infect. 2008 Jan;14(1):14-21
references.pmid: 18005178
references.citation: Am J Infect Control. 2004 Dec;32(8):470-85
references.pmid: 15573054
references.citation: N Engl J Med. 2000 Mar 9;342(10):710-21
references.pmid: 10706902
references.citation: J Clin Microbiol. 1996 Nov;34(11):2841-2
references.pmid: 8897196
references.citation: Braz J Infect Dis. 2005 Feb;9(1):64-9
references.pmid: 15947849
references.citation: Antimicrob Agents Chemother. 2002 Jun;46(6):1619-28
references.pmid: 12019066
references.citation: Saudi Med J. 2011 Sep;32(9):966-7
references.pmid: 21894365
references.citation: Crit Care Med. 2010 Aug;38(8 Suppl):S335-44
references.pmid: 20647791
references.citation: Emerg Infect Dis. 2001 Mar-Apr;7(2):183-7
references.pmid: 11294702